Frank Saran

10.7k citations

149 papers · 6.2k indexed · 1 hit paper · h-index 34

Impact in

Genetics top 0.1%
- Glioma Diagnosis and Treatment
Neurology top 1%
- Neuroblastoma Research and Treatments

Papers in

Genetics 96
- Glioma Diagnosis and Treatment 96
Radiation 25
- Advanced Radiotherapy Techniques 24

Co-authors: Warren Mason Ryo Nishikawa Roger Henriksson Olivier Chinot Wolfgang Wick Timothy F. Cloughesy Lauren E. Abrey Magalie Hilton
Journals: Neuro-Oncology (17 papers)Radiotherapy and Oncology (13 papers)International Journal of Radiation Oncology*Biology*Physics (13 papers)Journal of Clinical Oncology (13 papers)Clinical Oncology (11 papers)
Partner nations: United Kingdom Germany United States

In The Last Decade

Frank Saran

145 papers receiving 6.1k citations

Hit Papers

align trajectories log scale

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma 2014 · 1.8k citations

Peers

Countries citing papers authored by Frank Saran

Since Specialization

Citations

This map shows the geographic impact of Frank Saran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Saran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Saran more than expected).

Fields of papers citing papers by Frank Saran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Saran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Saran. The network helps show where Frank Saran may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Frank Saran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frank Saran Line = papers co-authored together Frank Saran links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeted Alpha Therapy for Glioblastoma: Review on In Vitro, In Vivo and Clinical Trials Targeted Oncology ·김호연, Tinatin Sydykova, Puthenparampil Wilson, Frank Saran, Eva Bezak	2024	3
2	Predicting Survival with Brain Metastases in the Stereotactic Radiosurgery Era: are Existing Prognostic Scores Still Relevant? Or Can we do Better? Clinical Oncology ·Matthew W. Fittall, Martin Brewer, Abubakar Mohammed Bichi, L. Kviat, Abdel Babiker, Duc Khanh Nguyen, Frank Saran, Tatsuo KIMURA, Francesca Soldà, Hue Le, Liam Welsh, R Vidhyalakshmi	2024	2
3	Survival after Stereotactic Radiosurgery in the Era of Targeted Therapy: Number of Metastases No Longer Matters Current Oncology ·Abubakar Mohammed Bichi, Martin Brewer, Matthew W. Fittall, 一成東, Karen Thomas, Shaohui Yin, Hue Le, Francesca Soldà, Tatsuo KIMURA, Heting Wang, Frank Saran, Liam Welsh, R Vidhyalakshmi	2024	1
4	Determining the Research Priorities for Adult Primary Brain Tumours in Australia and New Zealand: A Delphi Study with Consumers, Health Professionals, and Researchers Current Oncology ·Georgia Halkett, Lauren J. Breen, José Bustamante Vismara, Rashidah Mohammed Hamidi, Hao‐Wen Sim, Hui Gan, Benjamin Y. Kong, Anna K. Nowak, Bryan W. Day, Rosemary Harrup, Melissa James, Frank Saran, Tetsuichi Kaneko, Anslem O.C, Eng‐Siew Koh	2022	0
5	Determining the incidence of interstitial pneumonitis and chronic kidney disease following full intensity haemopoetic stem cell transplant conditioned using a forward-planned intensity modulated total body irradiation technique Radiotherapy and Oncology ·Emily Durie, Emma Nicholson, Chloe Anthias, 岡田俊, Mike Potter, Mark Ethell, Christina Messiou, Angélica Fuentes, Nilna Maulidatul Fitriyah, James Talbot, G. Smyth, Martí Belda P, Frank Saran, Henry Mandeville	2021	7
6	Geriatric assessment of glioblastoma patients is feasible and may provide useful prognostic information Neuro-Oncology Practice ·塩野麻子, Volodimir Didur, Mairi Mackinnon, 牛国兴, R. Rajnikanth, Kathryn Greenwood, Frank Saran, Anthony J. Chalmers, Juliet Brock	2019	7
7	Facing pseudoprogression after radiotherapy in low grade gliomas Translational Cancer Research ·Fernando Carceller, Henry Mandeville, Andrew D. MacKinnon, Frank Saran	2017	4
8	Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma Neuro-Oncology ·Wolfgang Wick, Olivier Chinot, Martin Bendszus, Warren Mason, Roger Henriksson, Frank Saran, Ryo Nishikawa, Cédric Révil, Yannick Kerloëguen, Timothy F. Cloughesy	2016	68
9	Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial Journal of Clinical Oncology ·Thomas Sandmann, Richard Bourgon, Josep Garcia, Congfen Li, Timothy F. Cloughesy, Olivier Chinot, Wolfgang Wick, Ryo Nishikawa, Warren Mason, Roger Henriksson, Frank Saran, Albert Lai, N. Moore, Samir Kharbanda, Franklin Peale, Priti S. Hegde, Lauren E. Abrey, Heidi Phillips, Carlos Bais	2015	208
10	Overview of Arterial Thromboembolic Events (ATEs) in AVAglio, a Randomized, Placebo-controlled Phase III Trial of Bevacizumab, Radiotherapy and Temozolomide (BEV+RT/TMZ) for Newly Diagnosed Glioblastoma (S22.003) Neurology ·Warren Mason, Timothy F. Cloughesy, Wolfgang Wick, Roger Henriksson, Frank Saran, Ryo Nishikawa, А.В. Павлов-Удовенко, Cédric Révil, Josep Garcia, Olivier Chinot	2014	1
11	HEALTH-RELATED QUALITY OF LIFE (HRQOL) ANALYSES IN THE AVAGLIO STUDY, A RANDOMIZED, PLACEBO-CONTROLLED PHASE III TRIAL OF BEVACIZUMAB, TEMOZOLOMIDE AND RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA Neuro-Oncology ·Martin Klein, Roger Henriksson, Andrew Bottomley, Timothy F. Cloughesy, Wolfgang Wick, Warren Mason, Frank Saran, Ryo Nishikawa, Arliene Ravelo, Magalie Hilton, Olivier Chinot	2013	4
12	FINAL EFFICACY AND SAFETY RESULTS FROM AVAglio, A PHASE III TRIAL OF BEVACIZUMAB (BEV) PLUS TEMOZOLOMIDE (TMZ) ANDRADIOTHERAPY (RT) IN NEWLY DIAGNOSED GLIOBLASTOMA Neuro-Oncology ·Olivier Chinot, Wolfgang Wick, Warren Mason, Roger Henriksson, Frank Saran, Ryo Nishikawa, Alain Carpentier, Khê Hoang‐Xuan, Petr Kavan, Dana Cernea, Alba A. Brandes, Magalie Hilton, Yannick Kerloëguen, Kerry Claire Jenkins, Andri Alfani	2013	3
13	Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis—an EORTC STBSG and ROG study (EORTC 62991–22998) Annals of Oncology ·Ronald B. Keus, Remi A. Nout, Jean‐Yves Blay, Jos M. de Jong, I. Hennig, Frank Saran, Julia Hartmann, Marie‐Pierre Sunyach, Stephen J. Gwyther, M. Ouali, A. Kirkpatrick, P Poortmans, Pancras C.W. Hogendoorn, Winette T.A. van der Graaf	2013	105
14	Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma Journal of Clinical Oncology ·Michael Brada, Sally Stenning, Rhian Gabe, Lindsay C Thompson, David E. Levy, R. Rampling, Sara Erridge, Frank Saran, Rao Gattamaneni, Kirsten Hopkins, S Lustgarden, V. Peter Collins, Siow Ming Lee	2010	178
15	Dosimetry for Fractionated ¹³¹ I-mIBG Therapies in Patients with Primary Resistant High-Risk Neuroblastoma: Preliminary Results Cancer Biotherapy and Radiopharmaceuticals ·Andrew Gaspar, Frank Saran, Mark N. Gaze, Sarah Chittenden, Mike Partridge, Donna Lancaster, Andrew D.J. Pearson, Glenn Flux	2007	42
16	Measurement of the immobilisation efficacy of a head fixation system Iranian Journal of radiation research ·Mohammad Amin Mosleh‐Shirazi, 勝又篤, Frank Saran, A.P. Warrington	2006	1
17	Feasibility of Dosimetry-Based High-Dose ¹³¹ I-Meta-Iodobenzylguanidine with Topotecan as a Radiosensitizer in Children with Metastatic Neuroblastoma Cancer Biotherapy and Radiopharmaceuticals ·Mark N. Gaze, Shuangbao Shu, Glenn Flux, 以一陳, Frank Saran, Simon Meller	2005	106
18	Recent advances in paediatric neuro-oncology Current Opinion in Neurology ·Frank Saran	2002	12
19	Stereotactically guided conformal radiotherapy for meningiomas Radiotherapy and Oncology ·H. Alheit, Frank Saran, A.P. Warrington, Ivan Rosenberg, Julian Perks, Rakesh Jalali, أ.م.د أسامة احمد عطا محمد, Charlotte Beardmore, Brigitta G. Baumert, M. Brada	1999	44
20	HIV-associated Cutaneous Kaposi's Sarcoma—Palliative Local Treatment by Radiotherapy Acta Oncologica ·Frank Saran, Irenäus A. Adamietz, Christoph Thilmann, Stephan Mose, H.D. Böttcher	1997	4

About Frank Saran

Frank Saran is a scholar working on Genetics, Radiation, Pulmonary and Respiratory Medicine, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 149 papers that have together received 6.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (96 papers), Brain Metastases and Treatment (42 papers), Advanced Radiotherapy Techniques (24 papers), Meningioma and schwannoma management (24 papers), Neuroblastoma Research and Treatments (16 papers), Radiation Therapy and Dosimetry (13 papers), Radiomics and Machine Learning in Medical Imaging (13 papers) and Medical Imaging Techniques and Applications (11 papers). The work is most often cited by research in Genetics (3.7k citations), Neurology (1.2k citations), Radiation (600 citations), Cancer Research (985 citations) and Pulmonary and Respiratory Medicine (1.8k citations). Frank Saran has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Warren Mason, Ryo Nishikawa, Roger Henriksson, Olivier Chinot, Wolfgang Wick, Timothy F. Cloughesy, Lauren E. Abrey, Magalie Hilton, Alain Carpentier and Alba A. Brandes. Their work appears in journals such as Neuro-Oncology, Radiotherapy and Oncology, International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology and Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact